Interaction of Viral Chemokine Inhibitors with Chemokines

  • Antonio Alcami
Part of the Methods in Molecular Biology™ book series (MIMB, volume 239)


Viruses modulate the chemokine network by encoding homologs of chemokines and chemokine receptors and secreted proteins that bind chemokines (1, 2, 3). These mechanisms have been identified in large DNA viruses such as herpesviruses and poxviruses. The exceptions are the chemokinelike activity of the human immunodeficiency virus (HIV) Tat protein and the mimicry of fractalkine by the glycoprotein G of respiratory syncytial virus.


Respiratory Syncytial Virus Chemokine Receptor Binding Medium Myxoma Virus Scintillation Proximity Assay 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Murphy, P. M. (2001) Viral exploitation and subversion of the immune system through chemokine mimicry. Nat. Immunol. 2, 116–122.PubMedCrossRefGoogle Scholar
  2. 2.
    Lalani, A. S., Barrett, J. W., and McFadden, G. (2000) Modulating chemokines: more lessons from viruses. Immunol. Today 21, 100–106.PubMedCrossRefGoogle Scholar
  3. 3.
    Alcami, A. and Koszinowski, U. H. (2000) Viral mechanisms of immune evasion. Immunol. Today 21, 447–455.PubMedCrossRefGoogle Scholar
  4. 4.
    Smith, P. V., Bryant, N. A., and Alcami, A. (2002) Soluble chemokine binding proteins encoded by viruses, in Chemokines and Viral Infections (Mahalingam, S., ed.), Landes Bioscience, Austin, TX.Google Scholar
  5. 5.
    Lalani, A. S., Graham, K., Mossman, K., et al. (1997) The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines. J. Virol. 71, 4356–4363.PubMedGoogle Scholar
  6. 6.
    Alcami, A., Symons, J. A., Collins, P. D., Williams, T. J., and Smith, G. L. (1998) Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J. Immunol. 160, 624–633.PubMedGoogle Scholar
  7. 7.
    Graham, K. A., Lalani, A. S., Macen, J. L., et al. (1997) The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology 229, 12–24.PubMedCrossRefGoogle Scholar
  8. 8.
    Smith, C. A., Smith, T. D., Smolak, P. J., et al. (1997) Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors. Virology 236, 316–327.PubMedCrossRefGoogle Scholar
  9. 9.
    Parry, C. M., Simas, J. P., Smith, V. P., et al. (2000) A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J. Exp. Med. 191, 573–578.PubMedCrossRefGoogle Scholar
  10. 10.
    van Berkel, V., Barrett, J., Tiffany, H. L., et al. (2000) Identification of a gamma-herpesvirus selective chemokine binding protein that inhibits chemokine action. J. Virol. 74, 6741–6747.PubMedCrossRefGoogle Scholar
  11. 11.
    Symons, J. A., Alcamí, A., and Smith, G. L. (1995) Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81, 551–560.PubMedCrossRefGoogle Scholar
  12. 12.
    Alcami, A. and Smith, G. L. (1992) A soluble receptor for interleukin-1β encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71, 153–167.PubMedCrossRefGoogle Scholar
  13. 13.
    Tsung, K., Yim, J. H., Marti, W., Buller, R. M. L., and Norton, J. A. (1996) Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light. J. Virol. 70, 165–171.PubMedGoogle Scholar
  14. 14.
    Spriggs, M. K., Hruby, D. E., Maliszewski, C. R., et al. (1992) Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell 71, 145–152.PubMedCrossRefGoogle Scholar
  15. 15.
    Dower, S. K., Kronheim, S. R., March, C. J., et al. (1985) Detection and characterization of high affinity plasma membrane receptors for human interleukin-1. J. Exp. Med. 162, 501–515.PubMedCrossRefGoogle Scholar
  16. 16.
    Bosworth, N. and Towers, P. (1989) Scintillation proximity assay. Nature 314, 167–168.CrossRefGoogle Scholar
  17. 17.
    Brown, B. A., Cain, M., Broadbent, J., et al. (1997) FlashPlate technology, in High Throughput Screening: The Discovery of Bioactive Substances (Devlin, J. P., ed.), Marcel Dekker, New York, pp. 317–328.Google Scholar
  18. 18.
    Komesli, S., Vivien, D., and Dutartre, P. (1998) Chimeric extracellular domain of type II transforming growth factor (TGF)-beta receptor fused to the Fc region of human immunoglobulin as a TGF-beta antagonist. Eur. J. Biochem. 254, 505–513.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2004

Authors and Affiliations

  • Antonio Alcami
    • 1
  1. 1.Department of Medicine and Division of Virology, Department of PathologyUniversity of CambridgeCambridgeUK

Personalised recommendations